Chordia Therapeutics Inc. (TYO:190A)
Japan
· Delayed Price · Currency is JPY 128.00
+4.00 (3.23%)
Mar 10, 2026, 9:51 AM JST
Chordia Therapeutics Market Cap
Chordia Therapeutics has a market cap or net worth of 9.04 billion as of March 9, 2026. Its market cap has decreased by -49.78% in one year.
Market Cap
9.04B
Enterprise Value
6.71B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
128.00
Market Cap Chart
Since June 14, 2024, Chordia Therapeutics's market cap has decreased from 12.58B to 9.04B, a decrease of -28.14%. That is a compound annual growth rate of -17.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 9.04B | 21.37% |
| Dec 30, 2025 | 7.45B | -65.16% |
| Dec 30, 2024 | 21.39B | 69.94% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Satudora Holdings | 11.60B |
| Tsubota Laboratory | 7.48B |
| Medical System Network | 15.08B |
| Pharmarise Holdings | 5.87B |
| Ohki Healthcare Holdings | 18.55B |
| Astena Holdings | 19.49B |
| YAKUODO HOLDINGS | 38.86B |
| Shinnihonseiyaku | 43.73B |